Cargando…
Identification of adenoid subtype characterized with immune-escaped phenotype in lung squamous carcinoma based on transcriptomics
Non-small cell lung cancer (NSCLC) is a heterogeneous disease, and its demarcation contributes to various therapeutic outcomes. However, a small subset of tumors shows different molecular features that are in contradiction with pathological classification. Unsupervised clustering was performed to su...
Autores principales: | Mei, Jie, Cai, Yun, Mussafi, Ofek, Zheng, Mingfeng, Xu, Yongrui, Chen, Ruo, Jiang, Guanyu, Mao, Wenjun, Xia, Wei, Wan, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555124/ https://www.ncbi.nlm.nih.gov/pubmed/36224612 http://dx.doi.org/10.1186/s40164-022-00327-5 |
Ejemplares similares
-
Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer
por: Mussafi, Ofek, et al.
Publicado: (2022) -
HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC
por: Mei, Jie, et al.
Publicado: (2022) -
Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer
por: Mao, Wenjun, et al.
Publicado: (2022) -
Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis
por: Wang, Xiaokun, et al.
Publicado: (2023) -
The Treatment of Tonsils and Adenoids
por: Kynaston, John
Publicado: (1921)